By integrating chronobiology with cardiology, BMAL1-centered interventions could redefine the management paradigm for ischemic heart disease, transforming chronobiological concepts from theoretical frameworks into clinical tools for personalized medicine. This evidence concerns the gene BMAL1 and coronary artery disorder.